AECOM which is a provider of professional technical and management support services to markets like transportation, facilities,environmental, etc has signed an exclusive agreement with Aquatech Systems Asia, for its biological treatment technology for industrial and municipal applications in the India market.
Aquatech Systems Asia, based in the city, is a wholly owned subsidiary of Aquatech International, USA. AECOM's design-build business in the UK has signed this agreement with Aquatech.
“Following extensive screening of the market for the most efficient and competitive sequence batch reactor (SBR) technology, we have identified that AECOM’s cyclic activated sludge system fits our needs. We are pleased to be working with AECOM’s design-build business. With this advanced SBR technology, we will enhance our position in the Indian waste water treatment market,” Devesh Sharma, managing director, Aquatech said.
Cyclic activated sludge system (CASS), an advanced SBR process, is a combination of biological selector and variable volume reactor process.
The process operates with a single sludge in a single reactor basin to accomplish both biological treatment and solids-liquid separation, thereby minimising the plant footprint.
“We are very excited about Aquatech’s capabilities and the enormous market potential for our CASS technology in India. Now we have found the right local partner and we are looking forward to pioneering this technology together in India,” said Malcolm Watchorn, programme manager for AECOM design-build. CASS SBR technology has successfully been applied in a large number of varied industrial and municipal plants round the globe. Some of these references have capacities in excess of 150 million liters per day and have innovative constructional features.
The two partners have already secured an assignment with Aquatech recently being awarded the integrated waste treatment and recycle-reuse project at Mumbai International Airport, which will feature CASS technology.
